Therorna
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Therorna - overview
Established
2021
Location
Beijing, -, China
Primary Industry
Biotechnology
About
Founded in 2021 and based in Beijing, China, Yuan Yin (Beijing) Biotechnology Co. , Ltd. operates as a biotechnology company that focuses on the research and application of circular RNA technology in the field of innovative drugs and therapeutics. The company's founder, Wei Wensheng, is the director of Peking University's Genome Editing Research Center.
The company's CEO, Daniel Tang, was the COO of Vanshi Biomedical. The company's CMO, Rick Xu, was the senior director of Jilin Wantong Group Co. , Ltd. The company focuses on developing new vaccines and innovative therapies by using circular RNA technology.
The company will focus on the pre-clinical and clinical studies for new drug pipelines.
Current Investors
Cenova Ventures, Quan Capital, Tencent Investment
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Biopharmaceuticals, Healthcare, Pharmaceuticals
Website
www.therorna.com
Verticals
Manufacturing
Company Stage
Series A
Total Amount Raised
Subscriber access only
Therorna - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.